These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6812363)

  • 1. Thrombocytopenia secondary to oxprenolol, a beta-blocking agent.
    Patrassi GM; Casonato A; Fabris F; Girolami A
    Acta Haematol; 1982; 68(1):75-6. PubMed ID: 6812363
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombocytopenia due to oxprenolol.
    Hare DL; Hicks BH
    Med J Aust; 1979 Sep; 2(5):259. PubMed ID: 514164
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombocytopenia due to slow-release oxprenolol.
    Dodds WN; Davidson RJ
    Lancet; 1978 Sep; 2(8091):683. PubMed ID: 80613
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug induced immune-thrombocytopenia.
    Hoigné R
    Acta Haematol; 1982; 68(1):1-2. PubMed ID: 6812350
    [No Abstract]   [Full Text] [Related]  

  • 5. Ocular reaction to oxprenolol. A case report.
    Lewis BS; Setzen M; Kokoris N
    S Afr Med J; 1976 Mar; 50(12):482-3. PubMed ID: 131980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled evaluation of the beta adrenoceptor blocking drug oxprenolol in anxiety.
    Johnson G; Singh B; Leeman M
    Med J Aust; 1976 Jun; 1(24):909-12. PubMed ID: 790112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
    Schröder R
    Z Kardiol; 1985; 74 Suppl 6():165-72. PubMed ID: 2869616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative anti-hypertensive effects of labetalol and the combination of oxprenolol and phentolamine.
    Johnson BF; LaBrooy J; Munro-Faure AD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):783-7. PubMed ID: 791332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a slow release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension.
    O'Brien KP; Stephens EJ
    N Z Med J; 1976 Aug; 84(570):142-4. PubMed ID: 1069924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of atenolol and oxprenolol in the treatment of arterial hypertension. A comparison.
    Turner AS; Watson OF; Brocklehurst JE
    Med J Aust; 1979 Jun; 1(13):625-6. PubMed ID: 386061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxprenolol and retroperitoneal fibrosis.
    McClusky DR; Donaldson RA; McGeown MG
    Br Med J; 1980 Nov; 281(6253):1459-60. PubMed ID: 7437836
    [No Abstract]   [Full Text] [Related]  

  • 12. Eruption during treatment with oxprenolol.
    Levene GM; Gange RW
    Br Med J; 1978 Mar; 1(6115):784. PubMed ID: 147124
    [No Abstract]   [Full Text] [Related]  

  • 13. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive pleural thickening during oxprenolol therapy.
    Page RL
    Br J Dis Chest; 1979 Apr; 73(2):195-9. PubMed ID: 534607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effect and side-effects of treatment with beta blockers- a comparative study between oxprenolol and propranolol.
    Andersson O; Berglund G; Bergman H; Cramer K; Fagerberg SE; Forsberg SA; Johnsen V; Lundkvist L; Rutle O; Sjolyst R
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):43-50. PubMed ID: 812664
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antihypertensive effect and adverse effects of treatment with beta-blocking agents].
    Andersson O; Berglund G; Bergman H; Cramér K; Fagerberg SE; Forsberg SA; Johnsen V; Lundkvist L; Rutle O; Sjolyst R
    Lakartidningen; 1975 Nov; 72(48):4738-40. PubMed ID: 1105030
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of a beta-blocking agent, oxprenolol, in the treatment of rhythm disorders].
    Broustet P; Lacut JY
    Bord Med; 1972 Oct; 5(16):2131-9. PubMed ID: 4640792
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperpigmentation associated with oxprenolol administration.
    Harrower AD; Strong JA
    Br Med J; 1977 Jul; 2(6082):296. PubMed ID: 871864
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxprenolol in hypertension.
    Marshall AJ; Barritt DW
    Br J Clin Pract; 1973 Sep; 27(9):337-40. PubMed ID: 4595073
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of oxprenolol and atenolol in the treatment of hypertension.
    Kamili MA; Allaqaband GQ; Ali G; Shah MY; Sheikh AS
    Indian Heart J; 1988; 40(6):471-4. PubMed ID: 3248806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.